“showed a trend”

Following the NS preceded by Cue 1/CS+, the iH values showed a trend toward deceleration for the +1 [ t (17) = 1.87, p = 0.079] and +2 [ t (17) = 1.93, p = 0.070] intervals.

Long-term incubation with COVID19 patient serum also had effects on cellular arrhythmogenic potential: Ca 2+ waves showed a trend to occur more often upon incubation with patient serum as compared to control (0.22 ± 0.04 vs 0.37 ± 0.04 (control vs patient), waves/sec, n = 32 vs 49, p = 0.079) and spontaneous Ca 2+ release events (i.e.

In the IPTW-adjusted cohort, low HER2 expression showed a trend towards better BCSS for TNBC (log-rank test P = 0.079, Additional file 3 : Figure S1).

Result PPN‐tau was significantly correlated with increased REM latency (p<0.001; Figure 1) and showed a trend‐level association with REM sleep percentage(REM %) (p=0.079).

Although not reaching statistical significance, NLR and RDW showed a trend toward higher values in patients with excess weight ( p = 0.079 and p = 0.076, respectively).

OmA MS ≤ 7 and CTA MS ≥ 8 showed a trend towards increased collagen type I positivity (p = 0.079 and p = 0.081, respectively; Mann-Whitney U test).

OCD severity (Yale-Brown Obsessive Compulsive Scale; primary outcome) analyzed using a pre-registered mixed linear model showed a trend level group difference at post-treatment (ES = −0.47; p = 0.079).

Among short-chain fatty acids, hexanoic acid (C6) showed a trend toward higher levels in sarcopenic patients ( p = 0.079).

Although not statistically significant, increased baseline FC (top quartile) showed a trend of association with time-to-clinical relapse (hazard ratio [HR] 2.58, P = 0.079, c-index = 0.607).

Interestingly, when toripalimab was administrated two days after chemotherapy rather than being used simultaneously, the combinational neoadjuvant regime showed a trend toward a higher pCR rate (36.4%, 4/11 versus 7.7%, 1/13, P = 0.079) ( 60 ).

In vascular patients, only the co‐presence of L‐FP‐TEMP‐MVIS showed a trend‐level differences (W = 1.99; p = 0.079), although mean intensity did not achieve a significant AUC (Table S2 ‐Vascular).

The time between diagnoses showed a trend for positive correlation with cancer-associated mut/Mb that did not reach statistical significance (Spearman’s rho 0.550, P = 0.079), and a corresponding sub-analysis of non-silent mutations showed a similar result (Spearman’s rho 0.495, P = 0.121).

Conversely, compared with the first to third quartiles (Q1-Q3, <0.333ug/ml), propionic acid in the fourth quartile (Q4,> 0.333ug/ml) showed a trend of lower 90-day mortality) (P = 0.079) ( Supplementary Figure S3 ).

There was no significant difference in total and subscale of PANSS score at one week and percentage changes of those at one week, however, the percentage change of PANSS positive scores at one week showed a trend level of difference (p=0.079) ( Table 1 ).

Only fasting glucose showed a trend with TSP-4 ( r = 0.092, p = 0.079).

The trial showed a trend toward improved median PFS with T + E (3.8 months vs. 1.9 months, HR 0.64, p = 0.079).

In addition, in +1730G/A polymorphism, GA and AA genotypes also showed a trend to higher E2 compared to GG genotype (p=0.079) ( Table 4 ).

The experimental group showed a trend toward a higher pCR rate ( P =0.079).

NonHRT‐women had significantly higher TPR ( F (1, 105) = 6.10, r = 0.24, p = 0.015) and showed a trend towards lower SV ( F (1, 105) = 3.14, r = 0.02, p = 0.079) compared to men.

The cytokines that showed statistically significant difference between the two groups of patients were the same cytokines which were significantly altered in ACLF vs no ACLF, with the only exception of VEGF-A, which showed a trend towards statistical significance (p = 0.079) ( Table 4 ).

At the end of the study, both dietary treatments had reduced these biomarker levels; the control group showed statistically significant changes ( p = 0.007), and the RESMENA group showed a trend towards significance ( p = 0.079).

Our enhanced Model 3 demonstrated exceptional predictive performance (AUC 0.929), statistically comparable to SOFA ( p = 0.052), and showed a trend toward superiority over APACHE II (AUC 0.900, p = 0.079).

While the presence of inhibitors showed a trend toward association with increased antithrombotic treatment ( p = 0.079), the relationship was not statistically significant.

In contrast, 18 F-FAPI extent was not significantly associated with LV volumes, but showed a trend toward an inverse relationship with LVEF (r=−0.580, P=0.079) ( Figure 5 and Figure S2 ).

EDA peak amplitude was also positively associated with WPI (ρ = 0.65, p = 0.041; large effect) and showed a trend with FM score (ρ = 0.58, p = 0.079; medium-to-large effect).